US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Onestream Inc

24.77

-0.0400-0.16%

Volume:1.09M

Turnover:27.07M

Market Cap:4.37B

PE:-14.02

High:25.10

Open:25.00

Low:24.40

Close:24.81

Loading ...

Overview Company News Filings

CFO William A. Koefoed Reports Disposal of OneStream Inc. Common Shares

AIM ImmunoTech Reports Positive Mid-year Safety and Efficacy Data from Phase 2 Study Evaluating Ampligen® (rintatolimod) in Combination with AstraZeneca’s Imfinzi® (durvalumab) for the Treatment of Pancreatic Cancer

Purple Biotech CEO Issues Letter to Shareholders Highlighting Pipeline Progress and Clinical Milestones Achieved in First Half of 2025

Ken Hohenstein, Chief Revenue Officer, Reports Disposal of OneStream Inc. Common Shares

OneStream Is Maintained at Neutral by Citigroup

Cue Biopharma Reports New Complete Response and Confirmed 50% Overall Response Rate in Ongoing Phase 1 Trial of CUE-101 and Pembrolizumab in Recurrent/Metastatic HPV+ Head and Neck Cancer

OneStream price target raised to $29 from $27 at Citi

SELLAS Meets All Primary Endpoints in Phase 2 Trial of SLS009 in r/r AML and Receives FDA Guidance to Advance into First-Line Therapy Study

BriaCell Adds Mayo Clinic to Phase 3 Study in Metastatic Breast Cancer

Adagene Announces Regulatory Update on Clinical Development Plan for Muzastotug in Microsatellite Stable Colorectal Cancer Following Productive Type B (End of Phase 1) Meeting with FDA

BriaCell’s Bria-IMT™ Demonstrates Survival Advantage over Trodelvy® and Control Group in Metastatic Breast Cancer

Director Jonathan D. Mariner Reports Disposal of OneStream Inc. Common Shares

OneStream Inc. Announces Upcoming Release of Second Quarter 2025 Financial Results

2 Unstoppable Growth Stocks to Hold for the Next 20 Years

CFO William A. Koefoed Reports Disposal of OneStream Inc. Common Shares

Ken Hohenstein, Chief Revenue Officer, Reports Disposal of OneStream Inc. Common Shares

CFO William A. Koefoed Reports Disposal of OneStream Inc. Common Shares

Is This Beaten-Down Cathie Wood Artificial Intelligence (AI) Stock a Buy?

OneStream Inc. CEO and President Thomas Anthony Shea Reports Disposal of Common Shares

Scott Berg’s Buy Rating on Onestream, Inc. Driven by Strong Sales Prospects and Strategic Growth Initiatives

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/OS/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"OS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OS\",,,,,undefined,":{"symbol":"OS","market":"US","secType":"STK","nameCN":"Onestream Inc","latestPrice":24.77,"timestamp":1753819200000,"preClose":24.81,"halted":0,"volume":1092803,"delay":0,"floatShares":69818472,"shares":176260091,"eps":-1.766751,"marketStatus":"Pre-Mkt","change":-0.04,"latestTime":"07-30 07:41:33 EDT","open":25,"high":25.1,"low":24.4,"amount":27069878.845953,"amplitude":0.028214,"askPrice":25.49,"askSize":43,"bidPrice":24.51,"bidSize":43,"shortable":3,"etf":0,"ttmEps":-1.766751,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1753882200000},"marketStatusCode":1,"adr":0,"listingDate":1721793600000,"exchange":"NASDAQ","adjPreClose":24.77,"postHourTrading":{"tag":"盘后","latestPrice":25.1,"preClose":24.77,"latestTime":"18:16 EDT","volume":119091,"amount":2951343.85,"timestamp":1753827407805},"volumeRatio":1.1372894414190284,"impliedVol":0.6115,"impliedVolPercentile":0.5582},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OS\",,,,,undefined,":{"symbol":"OS","floatShares":69818472,"roa":"-35.83%","roe":"-108.78%","lyrEps":-1.232998,"volumeRatio":1.1372894414190284,"shares":176260091,"dividePrice":0,"high":25.1,"amplitude":0.028214,"preClose":24.81,"low":24.4,"week52Low":16.6942,"pbRate":"10.57","psRate":"8.47","week52High":35.39,"institutionHeld":0,"latestPrice":24.77,"eps":-1.766751,"divideRate":0,"volume":1092803,"delay":0,"ttmEps":-1.766751,"open":25,"prevYearClose":28.52,"prevWeekClose":25.01,"prevMonthClose":28.3,"prevQuarterClose":28.3,"fiveDayClose":25.115,"twentyDayClose":28.3,"sixtyDayClose":22.06,"earningDate":1754496000000,"earningTime":"盘后"},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"OS\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2555401704","title":"CFO William A. Koefoed Reports Disposal of OneStream Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2555401704","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555401704?lang=en_us&edition=fundamental","pubTime":"2025-07-29 06:12","pubTimestamp":1753740734,"startTime":"0","endTime":"0","summary":"William A. Koefoed, the Chief Financial Officer of OneStream Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OneStream Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on July 28, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250728:nNDLb95yX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OS","BK4097"],"gpt_icon":0},{"id":"2554747927","title":"AIM ImmunoTech Reports Positive Mid-year Safety and Efficacy Data from Phase 2 Study Evaluating Ampligen® (rintatolimod) in Combination with AstraZeneca’s Imfinzi® (durvalumab) for the Treatment of Pancreatic Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2554747927","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554747927?lang=en_us&edition=fundamental","pubTime":"2025-07-28 21:00","pubTimestamp":1753707600,"startTime":"0","endTime":"0","summary":"Mid-year report of combination therapy demonstrates promising signs of both no significant toxicity and superior PFS and OSOCALA, Fla., July  28, 2025  (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE Am","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/28/3122523/29489/en/AIM-ImmunoTech-Reports-Positive-Mid-year-Safety-and-Efficacy-Data-from-Phase-2-Study-Evaluating-Ampligen-rintatolimod-in-Combination-with-AstraZeneca-s-Imfinzi-durvalumab-for-the-T.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PFS","OS","BK4195","BK4139","BK4097","BK4211","AIM","BK4557"],"gpt_icon":0},{"id":"2553521798","title":"Purple Biotech CEO Issues Letter to Shareholders Highlighting Pipeline Progress and Clinical Milestones Achieved in First Half of 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2553521798","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553521798?lang=en_us&edition=fundamental","pubTime":"2025-07-23 19:00","pubTimestamp":1753268400,"startTime":"0","endTime":"0","summary":"REHOVOT, Israel, July  23, 2025  (GLOBE NEWSWIRE) -- Purple Biotech Ltd. (\"Purple Biotech\" or \"the Company\") (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that seek","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/23/3120090/0/en/Purple-Biotech-CEO-Issues-Letter-to-Shareholders-Highlighting-Pipeline-Progress-and-Clinical-Milestones-Achieved-in-First-Half-of-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ITT","BK4161","OS","PFS","HR","LU2065732104.USD","LU0054578231.USD","BK4097","LU0053671581.USD","BK4203","BK4211","PRGS","BK4195","BK4225","ORR"],"gpt_icon":0},{"id":"2553047401","title":"Ken Hohenstein, Chief Revenue Officer, Reports Disposal of OneStream Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2553047401","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553047401?lang=en_us&edition=fundamental","pubTime":"2025-07-22 05:22","pubTimestamp":1753132931,"startTime":"0","endTime":"0","summary":"Ken Hohenstein, Chief Revenue Officer of OneStream Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OneStream Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on July 21, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250721:nNDLbN8Dy3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OS"],"gpt_icon":0},{"id":"2551121980","title":"OneStream Is Maintained at Neutral by Citigroup","url":"https://stock-news.laohu8.com/highlight/detail?id=2551121980","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551121980?lang=en_us&edition=fundamental","pubTime":"2025-07-16 23:02","pubTimestamp":1752678120,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/OS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  July 16, 2025 11:02 ET (15:02 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OS"],"gpt_icon":0},{"id":"2551128305","title":"Cue Biopharma Reports New Complete Response and Confirmed 50% Overall Response Rate in Ongoing Phase 1 Trial of CUE-101 and Pembrolizumab in Recurrent/Metastatic HPV+ Head and Neck Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2551128305","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551128305?lang=en_us&edition=fundamental","pubTime":"2025-07-16 20:00","pubTimestamp":1752667200,"startTime":"0","endTime":"0","summary":"Additional complete response (CR) observed in patient with multiple tumorsConfirmed overall response rate (ORR) of 50% in patients with combined positive score (CPS) ≥1, including 50% ORR in patients ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/16/3116333/0/en/Cue-Biopharma-Reports-New-Complete-Response-and-Confirmed-50-Overall-Response-Rate-in-Ongoing-Phase-1-Trial-of-CUE-101-and-Pembrolizumab-in-Recurrent-Metastatic-HPV-Head-and-Neck-C.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OS","PR","BK4213","BK4097","BK4161","BK4139","CUE","BK4124","ORR","CPS","CR"],"gpt_icon":0},{"id":"2551445551","title":"OneStream price target raised to $29 from $27 at Citi","url":"https://stock-news.laohu8.com/highlight/detail?id=2551445551","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551445551?lang=en_us&edition=fundamental","pubTime":"2025-07-16 17:55","pubTimestamp":1752659709,"startTime":"0","endTime":"0","summary":"Citi raised the firm’s price target on OneStream (OS) to $29 from $27 and keeps a Neutral rating on the shares as part of a Q2 preview for the appl...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/onestream-price-target-raised-to-29-from-27-at-citi-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/onestream-price-target-raised-to-29-from-27-at-citi-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4097","OS"],"gpt_icon":0},{"id":"2551216465","title":"SELLAS Meets All Primary Endpoints in Phase 2 Trial of SLS009 in r/r AML and Receives FDA Guidance to Advance into First-Line Therapy Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2551216465","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551216465?lang=en_us&edition=fundamental","pubTime":"2025-07-15 19:45","pubTimestamp":1752579900,"startTime":"0","endTime":"0","summary":"The Trial Exceeded Target Overall Response Rate (ORR) of 20%, with 44% Response Rate Among Patients with Acute Myeloid Leukemia-Myelodysplasia-Related Changes (AML MR) Treated at Optimal Dose of 30 mg","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/15/3115485/0/en/SELLAS-Meets-All-Primary-Endpoints-in-Phase-2-Trial-of-SLS009-in-r-r-AML-and-Receives-FDA-Guidance-to-Advance-into-First-Line-Therapy-Study.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4097","OS","SLS","ORR"],"gpt_icon":0},{"id":"2551610241","title":"BriaCell Adds Mayo Clinic to Phase 3 Study in Metastatic Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2551610241","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551610241?lang=en_us&edition=fundamental","pubTime":"2025-07-15 19:30","pubTimestamp":1752579000,"startTime":"0","endTime":"0","summary":"PHILADELPHIA and VANCOUVER, British Columbia, July  15, 2025  (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage bi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/15/3115474/0/en/BriaCell-Adds-Mayo-Clinic-to-Phase-3-Study-in-Metastatic-Breast-Cancer.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4097","BCTX","OS","BK4139","CPI"],"gpt_icon":0},{"id":"2551697271","title":"Adagene Announces Regulatory Update on Clinical Development Plan for Muzastotug in Microsatellite Stable Colorectal Cancer Following Productive Type B (End of Phase 1) Meeting with FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2551697271","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551697271?lang=en_us&edition=fundamental","pubTime":"2025-07-15 19:00","pubTimestamp":1752577200,"startTime":"0","endTime":"0","summary":"- Alignment gained on Phase 2 inclusion/exclusion criteria, primary and secondary endpoints, and study design, including sample size and dosing regimen - Company expects to begin enrolling patients in","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/15/3115441/0/en/Adagene-Announces-Regulatory-Update-on-Clinical-Development-Plan-for-Muzastotug-in-Microsatellite-Stable-Colorectal-Cancer-Following-Productive-Type-B-End-of-Phase-1-Meeting-with-F.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1929549753.HKD","SG9999014542.SGD","BK4211","LU1917777945.USD","LU1934455863.HKD","LU2324357040.USD","ADAG","SG9999015358.SGD","LU0965509283.SGD","IE00BSNM7G36.USD","LU1066051225.USD","LU1934455194.USD","LU1983299246.USD","LU2361045086.USD","LU0320765489.SGD","LU2461242641.AUD","LU2112291526.USD","BK4534","LU0289739699.SGD","BK4195","LU1066051811.HKD","IE00BBT3K403.USD","SG9999002224.SGD","LU0266013472.USD","LU0320765646.SGD","LU0106261372.USD","MRK","ORR","LU1061106388.HKD","LU1430594728.SGD","SG9999014559.SGD","LU1023059063.AUD","IE00B1BXHZ80.USD","SG9999001176.USD","IE00BJT1NW94.SGD","CRC","LU1941712264.USD","LU0265550359.USD","SOC","IE0002141913.USD","LU0965509101.SGD","LU0266512127.USD","LU1066053197.SGD","LU1699723380.USD","BK4550","OS","LU1066051498.USD","MSS","LU0211331839.USD","PFS"],"gpt_icon":0},{"id":"2550379958","title":"BriaCell’s Bria-IMT™ Demonstrates Survival Advantage over Trodelvy® and Control Group in Metastatic Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2550379958","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550379958?lang=en_us&edition=fundamental","pubTime":"2025-07-11 19:30","pubTimestamp":1752233400,"startTime":"0","endTime":"0","summary":"Median Overall Survival (OS) of 13.9 months in triple negative breast cancer (TNBC) exceeds Trodelvy (11.8 months) and doubles control (6.9 months)OS of 17.3 months in HR+ metastatic breast cancer sur","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/11/3113933/0/en/BriaCell-s-Bria-IMT-Demonstrates-Survival-Advantage-over-Trodelvy-and-Control-Group-in-Metastatic-Breast-Cancer.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCTX","BK4139","SG","CPI","MBC","BK4097","BK4209","OS","BK4086"],"gpt_icon":0},{"id":"2550663390","title":"Director Jonathan D. Mariner Reports Disposal of OneStream Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2550663390","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550663390?lang=en_us&edition=fundamental","pubTime":"2025-07-10 04:17","pubTimestamp":1752092259,"startTime":"0","endTime":"0","summary":"Jonathan D. Mariner, a Director at OneStream Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OneStream Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on July 09, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250709:nNDLbTpWS3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4097","OS"],"gpt_icon":0},{"id":"2549550648","title":"OneStream Inc. Announces Upcoming Release of Second Quarter 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2549550648","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549550648?lang=en_us&edition=fundamental","pubTime":"2025-07-08 04:30","pubTimestamp":1751920227,"startTime":"0","endTime":"0","summary":"OneStream Inc. will announce its second quarter 2025 financial results on August 7, 2025. The results will be released after the market close. A conference call and webcast to discuss the results will take place at 4:30 p.m. ET / 1:30 p.m. PT. The webcast can be accessed via OneStream's Investor website.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OneStream Inc. published the original content used to generate this news brief via PR Newswire  on July 07, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250707:nNDLzKS9l:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OS","BK4097"],"gpt_icon":0},{"id":"2549349026","title":"2 Unstoppable Growth Stocks to Hold for the Next 20 Years","url":"https://stock-news.laohu8.com/highlight/detail?id=2549349026","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549349026?lang=en_us&edition=fundamental","pubTime":"2025-07-05 23:10","pubTimestamp":1751728200,"startTime":"0","endTime":"0","summary":"Investing in top, market-beating stocks is a great way to generate lucrative returns over the long run.The two companies below have generally delivered superior market performances.They still boast excellent prospects for the next two decades.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/07/05/2-unstoppable-growth-stocks-to-hold-for-the-next-2/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["LU0472753341.HKD","LU0476273544.USD","LU0757359954.USD","LU1720051017.SGD","SG9999001424.SGD","LU1023059063.AUD","SG9999014542.SGD","IE0034235303.USD","LU0080751232.USD","LU2458330243.SGD","SG9999014559.SGD","LU1582987324.SGD","BK4585","LU1670711123.USD","LU0661504455.SGD","IE00BJLML261.HKD","IE00B1BXHZ80.USD","LU0640476718.USD","IE00B3S45H60.SGD","LU1935043536.SGD","LU2286300806.USD","IE00BJTD4N35.SGD","LU1917777945.USD","LU2463028550.USD","LU1084165304.USD","LU2552382132.HKD","LU2265009873.SGD","LU0094547139.USD","LU2360106780.USD","LU0006306889.USD","LU1366192091.USD","MSFT","LU0061474960.USD","BK4532","LU1066053197.SGD","LU2552382058.USD","LU0792757196.USD","LU1633808545.USD","LU0187121727.USD","OS","LU1582987597.SGD","LU2242650005.HKD","LU1340139317.AUD","SG9999015358.SGD","LU2362541273.HKD","ISRG","LU0784384876.USD","LU0683600562.USD","IE00BFSS8Q28.SGD","LU0689626769.HKD"],"gpt_icon":1},{"id":"2546729001","title":"CFO William A. Koefoed Reports Disposal of OneStream Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2546729001","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546729001?lang=en_us&edition=fundamental","pubTime":"2025-06-28 04:27","pubTimestamp":1751056022,"startTime":"0","endTime":"0","summary":"William A. Koefoed, the Chief Financial Officer of OneStream Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OneStream Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 27, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250627:nNDL7nRqxp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"CFO William A. Koefoed Reports Disposal of OneStream Inc. Common Shares","news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4097","OS"],"gpt_icon":0},{"id":"2545409944","title":"Ken Hohenstein, Chief Revenue Officer, Reports Disposal of OneStream Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2545409944","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545409944?lang=en_us&edition=fundamental","pubTime":"2025-06-24 04:49","pubTimestamp":1750711766,"startTime":"0","endTime":"0","summary":"Ken Hohenstein, Chief Revenue Officer of OneStream Inc., reported a disposal of Class A Common Stock shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OneStream Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 23, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250623:nNDLscGzB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Ken Hohenstein, Chief Revenue Officer, Reports Disposal of OneStream Inc. Common Shares","news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OS"],"gpt_icon":0},{"id":"2544900080","title":"CFO William A. Koefoed Reports Disposal of OneStream Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2544900080","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544900080?lang=en_us&edition=fundamental","pubTime":"2025-06-19 04:13","pubTimestamp":1750277587,"startTime":"0","endTime":"0","summary":"William A. Koefoed, Chief Financial Officer of OneStream Inc., reported a disposal of Class A Common Stock shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OneStream Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 18, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250618:nNDL54p2Xv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"CFO William A. Koefoed Reports Disposal of OneStream Inc. Common Shares","news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4097","OS"],"gpt_icon":0},{"id":"2543027620","title":"Is This Beaten-Down Cathie Wood Artificial Intelligence (AI) Stock a Buy?","url":"https://stock-news.laohu8.com/highlight/detail?id=2543027620","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543027620?lang=en_us&edition=fundamental","pubTime":"2025-06-16 17:30","pubTimestamp":1750066200,"startTime":"0","endTime":"0","summary":"Recursion could help revolutionize the way drugs are developed.Its approach would help cut costs and launch medicines faster.Yet, the company has yet to prove itself and remains a risky stock.Recursion Pharmaceuticals  is not the most famous artificial intelligence  stock on the market, but the biotech  company has attracted the attention of some big names. Recursion has partnered with the AI juggernaut Nvidia to build a powerful supercomputer, for example.It is also attracting interest from some prominent Wall Street figures, including Cathie Wood, the CEO of Ark Invest. The investment firm owns about $164 million worth of the stock, as of this writing. Yet, Recursion has not been performing well -- shares are down by 19% this year.Should investors take this opportunity to buy the stock on the dip?High risk, high rewardRecursion Pharmaceuticals has yet to show the kind of evidence that would convince most investors that its approach works. The compan","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/06/16/is-this-beaten-down-cathie-wood-ai-stock-a-buy/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["BK4543","AI","OS","BK4588","BK4023","BK4585","BK4097","ARKK","BK4528","BK4551","BK4587"],"gpt_icon":0},{"id":"2543477505","title":"OneStream Inc. CEO and President Thomas Anthony Shea Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2543477505","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543477505?lang=en_us&edition=fundamental","pubTime":"2025-06-13 04:55","pubTimestamp":1749761721,"startTime":"0","endTime":"0","summary":"Thomas Anthony Shea, the CEO and President of OneStream Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OneStream Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 12, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250612:nNDL93RsvS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"OneStream Inc. CEO and President Thomas Anthony Shea Reports Disposal of Common Shares","news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OS","BK4097"],"gpt_icon":0},{"id":"2542467309","title":"Scott Berg’s Buy Rating on Onestream, Inc. Driven by Strong Sales Prospects and Strategic Growth Initiatives","url":"https://stock-news.laohu8.com/highlight/detail?id=2542467309","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542467309?lang=en_us&edition=fundamental","pubTime":"2025-06-11 16:55","pubTimestamp":1749632135,"startTime":"0","endTime":"0","summary":"Needham analyst Scott Berg maintained a Buy rating on Onestream, Inc. Class A (OS – Research Report) today and set a price target of $38.00. Scott ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/scott-bergs-buy-rating-on-onestream-inc-driven-by-strong-sales-prospects-and-strategic-growth-initiatives-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/scott-bergs-buy-rating-on-onestream-inc-driven-by-strong-sales-prospects-and-strategic-growth-initiatives-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OS"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":191,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/OS\",params:#limit:5,,,undefined,":[{"date":"2025-08-07","symbol":"OS","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2025/06","expectedEps":0.01,"defaultRemindTime":1754596800000,"name":null,"time":"Post Market","dateTimestamp":1754539200000,"actualEps":null},{"market":"US","date":"2025-05-08","symbol":"OS","fiscalQuarterEnding":"2025/03","expectedEps":-0.03,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"post","actualEps":0.04},{"market":"US","date":"2025-02-11","symbol":"OS","fiscalQuarterEnding":"2024/12","expectedEps":0.02,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1739250000000,"reportTimeType":"post","actualEps":0.07},{"market":"US","date":"2024-11-07","symbol":"OS","fiscalQuarterEnding":"2024/09","expectedEps":0,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"post","actualEps":-1.06},{"market":"US","date":"2024-09-03","symbol":"OS","fiscalQuarterEnding":"2024/06","expectedEps":-0.11,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1725336000000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"OS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"OS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.5714,"hold":0.0952,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5714,"analysts":21,"updateTime":1753329600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/OS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"OS","date":"2025-07-29","current":-18.588158,"percent":0.832653,"low":-1655.61542,"twenty":-430.001496,"median":-26.065361,"eighty":-18.752986,"high":-14.493656,"avg":-324.306428,"sd":560.783679,"marketCap":4373012857},"quantilePoints":[{"date":"2024-08-02","current":-402.058638,"twenty":-402.058638,"median":-402.058638,"eighty":-402.058638,"marketCap":4348264172},{"date":"2024-08-09","current":-394.529993,"twenty":-398.004752,"median":-394.602383,"eighty":-391.489578,"marketCap":4266841869},{"date":"2024-08-16","current":-420.156344,"twenty":-402.058638,"median":-395.977809,"eighty":-394.529993,"marketCap":4543990864},{"date":"2024-08-23","current":-418.563746,"twenty":-420.156344,"median":-400.248867,"eighty":-394.674774,"marketCap":4526766915},{"date":"2024-08-30","current":-439.701867,"twenty":-427.829772,"median":-415.668113,"eighty":-395.977809,"marketCap":4755375690},{"date":"2024-09-06","current":-1412.285699,"twenty":-434.093948,"median":-420.156344,"eighty":-395.977809,"marketCap":4652069092},{"date":"2024-09-13","current":-1421.532228,"twenty":-630.517125,"median":-426.381956,"eighty":-397.599363,"marketCap":4682527160},{"date":"2024-09-20","current":-1491.611188,"twenty":-1406.835113,"median":-428.55368,"eighty":-398.352228,"marketCap":4913367253},{"date":"2024-09-27","current":-1641.015636,"twenty":-1479.542034,"median":-435.672004,"eighty":-401.33473,"marketCap":5405505506},{"date":"2024-10-04","current":-1582.129844,"twenty":-1582.616503,"median":-445.348351,"eighty":-408.313205,"marketCap":5211535706},{"date":"2024-10-11","current":-1384.546111,"twenty":-1557.991535,"median":-1361.673117,"eighty":-414.50986,"marketCap":4560694889},{"date":"2024-10-18","current":-1422.505547,"twenty":-1506.405635,"median":-1387.466067,"eighty":-417.984619,"marketCap":4685733272},{"date":"2024-10-25","current":-1513.510863,"twenty":-1501.052381,"median":-1410.582391,"eighty":-419.837824,"marketCap":4985504782},{"date":"2024-10-31","current":-1488.204572,"twenty":-1545.825049,"median":-1419.58559,"eighty":-422.588676,"marketCap":4902145859},{"date":"2024-11-08","current":-29.444986,"twenty":-1544.267739,"median":-1421.532228,"eighty":-422.588676,"marketCap":5359016876},{"date":"2024-11-15","current":-29.547337,"twenty":-1525.190689,"median":-1414.232336,"eighty":-406.749563,"marketCap":5377644907},{"date":"2024-11-22","current":-27.361909,"twenty":-1504.167001,"median":-1405.472467,"eighty":-395.977809,"marketCap":4979894851},{"date":"2024-11-29","current":-26.339693,"twenty":-1496.769778,"median":-1384.546111,"eighty":-392.705744,"marketCap":4793850470},{"date":"2024-12-06","current":-28.33551,"twenty":-1493.655158,"median":-903.058146,"eighty":-29.829328,"marketCap":5157091209},{"date":"2024-12-13","current":-28.454992,"twenty":-1490.248542,"median":-439.701867,"eighty":-28.749622,"marketCap":5178836972},{"date":"2024-12-20","current":-27.223413,"twenty":-1484.895288,"median":-431.521704,"eighty":-28.258307,"marketCap":4954688343},{"date":"2024-12-27","current":-27.048786,"twenty":-1479.834029,"median":-428.191726,"eighty":-28.004145,"marketCap":4922906075},{"date":"2025-01-03","current":-25.973452,"twenty":-1479.444702,"median":-426.381956,"eighty":-27.732022,"marketCap":4727194212},{"date":"2025-01-10","current":-24.227183,"twenty":-1479.444702,"median":-422.183287,"eighty":-27.252823,"marketCap":4409371530},{"date":"2025-01-17","current":-26.460569,"twenty":-1468.54353,"median":-415.668113,"eighty":-26.869269,"marketCap":4815850013},{"date":"2025-01-24","current":-27.894348,"twenty":-1465.818237,"median":-402.058638,"eighty":-26.861301,"marketCap":5076799163},{"date":"2025-01-31","current":-27.407231,"twenty":-1462.314289,"median":-396.991281,"eighty":-26.925021,"marketCap":4988143362},{"date":"2025-02-07","current":-27.09474,"twenty":-1459.102337,"median":-394.674774,"eighty":-26.925021,"marketCap":4931269830},{"date":"2025-02-14","current":-19.646244,"twenty":-1457.642359,"median":-390.041762,"eighty":-26.782239,"marketCap":4247537655},{"date":"2025-02-21","current":-19.437413,"twenty":-1455.695721,"median":-30.305187,"eighty":-26.72172,"marketCap":4202388031},{"date":"2025-02-28","current":-18.385222,"twenty":-1452.094441,"median":-29.520901,"eighty":-26.562732,"marketCap":3974903390},{"date":"2025-03-07","current":-18.486889,"twenty":-1446.059864,"median":-28.777108,"eighty":-26.339693,"marketCap":3996883783},{"date":"2025-03-14","current":-16.449855,"twenty":-1440.122619,"median":-28.454992,"eighty":-26.179328,"marketCap":3556475076},{"date":"2025-03-21","current":-17.921046,"twenty":-1437.981318,"median":-28.198548,"eighty":-25.317223,"marketCap":3874548031},{"date":"2025-03-28","current":-18.76981,"twenty":-1430.38943,"median":-27.986257,"eighty":-24.094834,"marketCap":4058051659},{"date":"2025-04-04","current":-16.296269,"twenty":-1422.116219,"median":-27.889753,"eighty":-20.198845,"marketCap":3523269657},{"date":"2025-04-11","current":-15.87621,"twenty":-1419.974918,"median":-27.820821,"eighty":-19.520945,"marketCap":3432452458},{"date":"2025-04-17","current":-15.802935,"twenty":-1417.346957,"median":-27.682957,"eighty":-19.180725,"marketCap":3416610370},{"date":"2025-04-25","current":-17.317281,"twenty":-1415.400319,"median":-27.425612,"eighty":-18.846182,"marketCap":3744013527},{"date":"2025-05-02","current":-17.960471,"twenty":-1411.604376,"median":-27.370467,"eighty":-18.532156,"marketCap":3883071858},{"date":"2025-05-09","current":-18.233962,"twenty":-1408.19776,"median":-27.329108,"eighty":-18.405555,"marketCap":4289685457},{"date":"2025-05-16","current":-21.240398,"twenty":-1401.871187,"median":-27.223413,"eighty":-18.515128,"marketCap":4996973579},{"date":"2025-05-23","current":-21.307828,"twenty":-1386.882076,"median":-27.071763,"eighty":-18.645114,"marketCap":5012836988},{"date":"2025-05-30","current":-20.970679,"twenty":-1384.546111,"median":-26.979854,"eighty":-18.713226,"marketCap":4933519947},{"date":"2025-06-06","current":-21.779837,"twenty":-1366.053052,"median":-26.837395,"eighty":-18.714534,"marketCap":5123880845},{"date":"2025-06-13","current":-21.083062,"twenty":-1357.293182,"median":-26.745487,"eighty":-18.76981,"marketCap":4959958960},{"date":"2025-06-20","current":-21.397734,"twenty":-630.517125,"median":-26.722672,"eighty":-18.799724,"marketCap":5033988198},{"date":"2025-06-27","current":-20.715944,"twenty":-446.043303,"median":-26.635196,"eighty":-18.835877,"marketCap":4873591516},{"date":"2025-07-03","current":-19.974216,"twenty":-441.960461,"median":-26.551186,"eighty":-18.852455,"marketCap":4699094026},{"date":"2025-07-11","current":-19.329886,"twenty":-438.862005,"median":-26.400131,"eighty":-18.891318,"marketCap":4547510347},{"date":"2025-07-18","current":-18.603142,"twenty":-435.145985,"median":-26.322706,"eighty":-18.792246,"marketCap":4376538059},{"date":"2025-07-25","current":-18.767971,"twenty":-431.217662,"median":-26.184843,"eighty":-18.769074,"marketCap":4415315279},{"date":"2025-07-29","current":-18.588158,"twenty":-430.001496,"median":-26.065361,"eighty":-18.752986,"marketCap":4373012857}],"updateTime":1753869261241}}}